WESPAC Advisors SoCal LLC decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,160 shares of the medical equipment provider’s stock after selling 313 shares during the period. Intuitive Surgical makes up 1.0% of WESPAC Advisors SoCal LLC’s portfolio, making the stock its 27th biggest holding. WESPAC Advisors SoCal LLC’s holdings in Intuitive Surgical were worth $1,513,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Oregon Public Employees Retirement Fund raised its position in Intuitive Surgical by 31,963.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 14,679,377 shares of the medical equipment provider’s stock valued at $31,000 after acquiring an additional 14,633,595 shares in the last quarter. Financial Advantage Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $36,000. Moody National Bank Trust Division bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $38,000. Exane Derivatives bought a new position in Intuitive Surgical during the fourth quarter worth $39,000. Finally, Quad Cities Investment Group LLC bought a new position in Intuitive Surgical during the fourth quarter worth $48,000. Institutional investors own 84.75% of the company’s stock.
Shares of NASDAQ:ISRG traded down $0.23 on Wednesday, hitting $547.94. The stock had a trading volume of 5,699 shares, compared to its average volume of 731,344. Intuitive Surgical, Inc. has a twelve month low of $393.57 and a twelve month high of $581.12. The company has a market capitalization of $62.76 billion, a PE ratio of 57.56, a P/E/G ratio of 4.15 and a beta of 1.12.
ISRG has been the topic of a number of research reports. Citigroup dropped their target price on shares of Intuitive Surgical from $606.00 to $601.00 and set a “buy” rating on the stock in a research report on Thursday, November 29th. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $615.00 target price on the stock in a research report on Wednesday, December 5th. Stifel Nicolaus dropped their target price on shares of Intuitive Surgical from $600.00 to $570.00 and set a “buy” rating on the stock in a research report on Friday, January 25th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $620.00 target price on shares of Intuitive Surgical in a research report on Friday, January 25th. Finally, BidaskClub lowered shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, January 30th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $566.40.
In other news, CEO Gary S. Guthart sold 28,085 shares of the company’s stock in a transaction dated Monday, December 3rd. The stock was sold at an average price of $542.78, for a total value of $15,243,976.30. Following the completion of the sale, the chief executive officer now directly owns 368,704 shares of the company’s stock, valued at approximately $200,125,157.12. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Jamie Samath sold 227 shares of the company’s stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $541.86, for a total value of $123,002.22. Following the completion of the sale, the vice president now directly owns 138 shares of the company’s stock, valued at $74,776.68. The disclosure for this sale can be found here. Insiders have sold a total of 66,512 shares of company stock valued at $35,318,293 over the last three months. Company insiders own 2.20% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was originally published by Dakota Financial News and is the sole property of of Dakota Financial News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://dakotafinancialnews.com/2019/02/20/wespac-advisors-socal-llc-trims-stake-in-intuitive-surgical-inc-isrg.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Featured Article: Stock Symbols, CUSIP and Other Stock Identifiers
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.